Carl Zeiss Meditec Ag VISULENS 550 REF 2268-038 - Product Usage: is a device for measuring the re...

FDA Device Recall #Z-0613-2021 — Class II — August 6, 2020

Recall Summary

Recall Number Z-0613-2021
Classification Class II — Moderate risk
Date Initiated August 6, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Carl Zeiss Meditec AG
Location Jena, N/A
Product Type Devices
Quantity 603 units

Product Description

Carl Zeiss Meditec Ag VISULENS 550 REF 2268-038 - Product Usage: is a device for measuring the refractive power of contact lenses and spectacle lenses and displaying measurement values for sphere, cylinder and prism.

Reason for Recall

Due to the incorrect DC/DC converter being assembled onto the communication board. As a result the effectiveness of the communication board cannot be guaranteed in that the safety function of the board would be insufficient resulting in an increased leakage of current and potentially cause electrical shocks to the user.

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, KS, KY, LA, MD, MI, MN, NC, NE, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, SC, TX, UT, VA, WA and WY. The countries of Argentina, Austria, Australia, Belgium, Bolivia, Canada, Colombia, Croatia, Cyprus, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Japan, Latvia, Luxembourg, Malaysia, Maldives, Netherlands, Portugal, Singapore, South Africa, South Korea, Spain, Switzerland, Taiwan, Turkey, and United Kingdom.

Lot / Code Information

Model: VISUREF 150 Catalog Number: 000000-2227-967 Serial Numbers: Pending

Other Recalls from Carl Zeiss Meditec AG

Recall # Classification Product Date
Z-1007-2022 Class II ZEISS miLOOP Lens Fragmentation Device REF 3030... Mar 16, 2022
Z-1133-2021 Class II IOLMaster 700 Dec 7, 2020
Z-0614-2021 Class II Carl Zeiss Meditec AG VISUREF150 REF 2227-967 -... Aug 6, 2020
Z-0108-2019 Class II Carl Zeiss Meditec AG, Goeschwitzer Strasse 51-... Jun 25, 2018
Z-0001-2018 Class II Carl Zeiss INTRABEAM PRS 500, product #304534-0... Aug 30, 2017

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.